StockNews.com cut shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a sell rating in a research note issued to investors on Monday morning. Several other research firms also recently commented on KURA. Wedbush reiterated an outperform rating and issued a $37.00 price objective on shares of Kura Oncology in a […]